Flagship explainer
How PHATHOM PHARMACEUTICALS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $175M | 100% |
| |
| Cost of revenue | $22.6M | 13% |
|
| $153M | 87% |
| |
| −$160M | −91% |
| |
| Income before tax | −$221M | −126% |
|
| Income tax | $0 | 0% |
|
| −$221M | −126% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-073379